Compounds > fluoxetine

fluoxetine and nadp

fluoxetine has been researched along with nadp in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albert, RH; Jin, Y; Lewis, M; Palackal, NT; Penning, TM; Stayrook, SE1
Murray, K; Murray, M1
Crespi, CL; Dandeneau, AA; Dehal, SS; Ho, T; Mason, AK; Morgan, L; Perloff, ES; Stresser, DM1
Filipović, D; Todorović, N1
Asuquo, EB; Dalmizrak, O; Ogus, IH; Ozer, N; Teralı, K1

Other Studies

5 other study(ies) available for fluoxetine and nadp

ArticleYear
Crystal structure of human type III 3alpha-hydroxysteroid dehydrogenase/bile acid binding protein complexed with NADP(+) and ursodeoxycholate.
    Biochemistry, 2001, Aug-28, Volume: 40, Issue:34

    Topics: Allosteric Regulation; Allosteric Site; Amino Acid Sequence; Binding Sites; Cloning, Molecular; Computer Simulation; Crystallography, X-Ray; Escherichia coli; Fluoxetine; Humans; Hydroxysteroid Dehydrogenases; Models, Molecular; Molecular Conformation; Molecular Sequence Data; NADP; Protein Binding; Protein Structure, Secondary; Recombinant Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Ursodeoxycholic Acid

2001
Mechanism-based inhibition of CYP activities in rat liver by fluoxetine and structurally similar alkylamines.
    Xenobiotica; the fate of foreign compounds in biological systems, 2003, Volume: 33, Issue:10

    Topics: Adrenergic Uptake Inhibitors; Amines; Animals; Aryl Hydrocarbon Hydroxylases; Binding Sites; Cytochrome P450 Family 2; Desipramine; Diffusion; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluoxetine; Heme; Hydroxylation; Inhibitory Concentration 50; Kinetics; Liver; Male; Microsomes, Liver; Models, Chemical; NADP; Nortriptyline; Oxygen; Protein Binding; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Steroid 16-alpha-Hydroxylase; Steroids; Time Factors

2003
Differential time- and NADPH-dependent inhibition of CYP2C19 by enantiomers of fluoxetine.
    Drug metabolism and disposition: the biological fate of chemicals, 2009, Volume: 37, Issue:4

    Topics: Aryl Hydrocarbon Hydroxylases; Chromatography, Liquid; Cytochrome P-450 CYP2C19; Fluoxetine; Humans; Microsomes, Liver; NADP; Selective Serotonin Reuptake Inhibitors; Stereoisomerism; Tandem Mass Spectrometry

2009
Prefrontal cortical glutathione-dependent defense and proinflammatory mediators in chronically isolated rats: Modulation by fluoxetine or clozapine.
    Neuroscience, 2017, 07-04, Volume: 355

    Topics: Animals; Antidepressive Agents; Clozapine; Cytokines; Defense Mechanisms; Disease Models, Animal; Fluoxetine; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Male; Mood Disorders; NADP; NF-kappa B; Nitric Oxide Synthase Type II; Prefrontal Cortex; Rats; Rats, Wistar; Social Isolation

2017
The Relevance of Glutathione Reductase Inhibition by Fluoxetine to Human Health and Disease: Insights Derived from a Combined Kinetic and Docking Study.
    The protein journal, 2019, Volume: 38, Issue:5

    Topics: Antidepressive Agents, Second-Generation; Cytochrome P-450 CYP2D6 Inhibitors; Enzyme Inhibitors; Fluoxetine; Glutathione Reductase; Humans; Kinetics; Molecular Docking Simulation; NADP; Selective Serotonin Reuptake Inhibitors

2019